Clinical Trial Update: Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin [NA]

View source ↗

Summary

A clinical trial update examining immune mechanisms after radiofrequency ablation of pulmonary metastases originating from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pulmonary Metastasis

Snippet

Sponsor: Institut Bergonié | Conditions: Immune Evasion, Tumor, Neoplastic Cells, Circulating | NA | Status: TERMINATED | Results posted: 2025-10-24